Wapnick Pamela
Chief Financial Officer · 6 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | MGX | Metagenomi Therapeutics, Inc. | Sale | 2,884 | $1.30 | $3,746.32 | filing |
| 2026-04-01 | MGX | Metagenomi Therapeutics, Inc. | Award | 24,000 | $0.00 | $0.00 | filing |
| 2026-03-05 | MGX | Metagenomi Therapeutics, Inc. | Sale | 1,581 | $1.60 | $2,529.60 | filing |
| 2025-12-05 | MGX | Metagenomi Therapeutics, Inc. | Sale | 1,576 | $1.77 | $2,792.51 | filing |
| 2025-12-01 | MGX | Metagenomi Therapeutics, Inc. | Award | 120,000 | $1.60 | $192,000.00 | filing |
| 2025-09-05 | MGX | Metagenomi Therapeutics, Inc. | Sale | 1,576 | $1.81 | $2,852.56 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.